О чем молчит печень. Как уловить сигналы самого крупного внутреннего органа, который предпочитает оставаться в тени

18. Shahid I., AlMalki W.H., Hassan S., Hafeez M.H. Real-world challenges for hepatitis C virus medications: a critical overview. Crit Rev Microbiol. 2018 Mar. 44 (2): 143–160.

19. Te H.S., Jensen D.M. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010 Feb. 14 (1): 1–21, vii.

20. Kuo A., Gish R. Chronic hepatitis B infection. Clin Liver Dis. 2012 May. 16 (2): 347–369.

21. Lau J.Y., Wright T.L. Molecular virology and pathogenesis of hepatitis B. Lancet. 1993 Nov 27. 342 (8883): 1335–1340.

22. [Guideline] Terrault N.A., Lok A.S.F., McMahon B.J. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 Apr. 67 (4): 1560–1599.

23. [Guideline] European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug. 67 (2): 370–398.

24. Schiff E.R., Lee S.S., Chao Y.C. et al. Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2011 Mar. 9 (3): 274–276.

25. Hoofnagle J.H. Reactivation of hepatitis B. Hepatology. 2009 May. 49(5 suppl):S156-65.

26. Bean P. Latest discoveries on the infection and coinfection with hepatitis D virus. Am Clin Lab. 2002 Jun. 21 (5): 25–27.

27. Xiridou M., Borkent-Raven B., Hulshof J., Wallinga J. How hepatitis D virus can hinder the control of hepatitis B virus. PLoS One. 2009. 4 (4): e5247.

28. Abbas Z., Afzal R. Life cycle and pathogenesis of hepatitis D virus: a review. World J Hepatol. 2013 Dec 27. 5 (12): 666–675.

29. Bahcecioglu I.H., Sahin A. Treatment of delta hepatitis: today and in the future – a review. Infect Dis (Lond). 2017 Apr. 49 (4): 241–250.

30. Alfaiate D., Deny P., Durantel D. Hepatitis delta virus: from biological and medical aspects to current and investigational therapeutic options. Antiviral Res. 2015 Oct. 122: 112–129.

31. Goyal A., Murray J.M. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication. Theor Popul Biol. 2016 Dec. 112: 60–69.

Часть 2. Глава 6

1. Strassburg C.P., Manns M.P. Treatment of autoimmune hepatitis. Semin Liver Dis. 2009 Aug. 29 (3): 273–285.

2. Longhi M.S, Ma. Y., Mieli-Vergani G., Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010 Feb. 34 (1): 7–14.

3. Vento S., Cainelli F. Is there a role for viruses in triggering autoimmune hepatitis? Autoimmun Rev. 2004 Jan. 3 (1): 61–69.

4. Umemura T., Ota M. Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis. Clin J Gastroenterol. 2015 Dec. 8 (6): 360–366.

5. Czaja A.J. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis. 2015 Feb. 19 (1): 57–79.

6. [Guideline] Gleeson D., Heneghan M.A. British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011 Dec. 60 (12): 1611–1629.

7. Floreani A., Rizzotto E.R., Ferrara F. et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005 Jul. 100 (7): 1516–1522.

8. [Guideline] Manns M.P., Czaja A.J., Gorham J.D. et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010 Jun. 51 (6): 2193–2213.

Часть 2. Глава 7

1. Gottesman L.E., Del Vecchio M.T., Aronoff S.C. Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects. BMC Pediatr. 2015 Nov 20. 15: 192.

2. Gotze T., Blessing H., Grillhosl C., Gerner P., Hoerning A. Neonatal cholestasis – differential diagnoses, current diagnostic procedures, and treatment. Front Pediatr. 2015. 3: 43.

3. Davis A.R., Rosenthal P., Escobar G.J., Newman T.B. Interpreting conjugated bilirubin levels in newborns. J Pediatr. 2011 Apr. 158 (4): 562–565.e1.

4. Memon N., Weinberger B.I., Hegyi T., Aleksunes L.M. Inherited disorders of bilirubin clearance. Pediatr Res. 2016 Mar. 79 (3): 378–386.

5. van Dijk R., Beuers U., Bosma P.J. Gene replacement therapy for genetic hepatocellular jaundice. Clin Rev Allergy Immunol. 2015 Jun. 48 (2–3): 243–253.

6. Sticova E., Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013 Oct 14. 19 (38): 6398–6407.

Часть 2. Глава 8

1. Stanley S.L. Jr. Amoebiasis. Lancet. 2003 Mar 22. 361 (9362): 1025–1034.

2. Acuna-Soto R., Maguire J.H., Wirth D.F. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol. 2000 May. 95 (5): 1277–1283.